This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
US-FDA 2016;Pageshttps://www.fda.gov/media/97468/download on 5/9/2019.
US-FDA 2016;Pages. Accessed at Drugs@FDA at https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/125544Orig1s000SumR.pdf on 4/22/2019.
Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083-107.
2013;Pageshttps://www.accessdata.fda.gov/drugsatfda_docs/label/2013/103772s5359lbl.pdf on 6/3/2019.
Kozlowski S, Birger N, Brereton S, McKean SJ, Wernecke M, Christl L, et al. Uptake of the Biologic Filgrastim and Its Biosimilar Product Among the Medicare Population. JAMA. 2018;320(9):929-31.
We thank Dr. Sarah Dutcher of the Office of Surveillance and Epidemiology Center for Drug Evaluation and Research (CDER), US FDA, for analysis and interpretation of data and Dr. Sarah Yim of the Office of Therapeutic Biologics and Biosimilars in the Office of New Drugs, CDER, US FDA, for critical review of this manuscript. We also thank Mr. Victor Shiau of Acumen, LLC, for analysis and interpretation of data and Mr. Andrew Kwist of Acumen, LLC, for critical revision of this manuscript.
No external funding support; funding by FDA and CMS.
This study was determined to meet the requirements of a Public Health Surveillance activity by the FDA/Center for Drug Evaluation and Research Human Subjects Protection Liaison to the FDA IRB.
Conflict of Interest
The authors declare that they do not have a conflict of interest.
This manuscript reflects the views of the authors and should not be construed to represent FDA’s or CMS’s views or policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Kozlowski, S., Flowers, N., Birger, N. et al. Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population. J GEN INTERN MED (2020). https://doi.org/10.1007/s11606-020-05957-1